- Business Wire•22 hours agoIpsen appoints Harout Semerjian as President, Head of Specialty Care International Region & Global Franchises
- Investopedia•11 days ago
Merrimack will sell some cancer drugs in a $1 billion deal and will lay off 80% of its workforce.
- TheStreet.com•12 days ago
The Nasdaq-listed cancer drug developer is up 43% in premarket trading after promising shareholders special dividends worth more than its closing share price on Friday.
IPSEY : Summary for IPSEN SPONS ADR EA REPR 0.25 OR - Yahoo Finance
Ipsen S.A. (IPSEY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||19.21 - 19.21|
|52 Week Range||15.94 - 19.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||25.85|
|Dividend & Yield||0.24 (1.22%)|
|1y Target Est||N/A|